Grow Therapy AI Visibility Market Strategy Report - Online Therapy

Answer Capsule

Grow Therapy is the strongest challenger in the Online Therapy category, holding 51.74% valid recommendation coverage in October 2026, third behind Talkspace at 75.8% and BetterHelp at 64.2%. The brand recorded the largest baseline-to-current gain in the category, up 12.3 points since July 2026, and it is the only tracked brand that rose in each of the three months measured. Its clearest weakness is first-position placement: a 16.33% rank-one rate against a 41.47% top-three rate means most of its recommendation credit sits below first place. Its clearest opportunity is converting that rising shortlist presence into first-choice placement inside the Brand Recommendation cluster, where all 545 qualified observations in October 2026 were concentrated.

Who This Report Is For

This report is written for Grow Therapy's marketing, growth, and executive teams, and for category analysts tracking how online therapy brands are recommended across AI and search surfaces.

Report Card

Executive Summary

Grow Therapy enters October 2026 as the category's strongest challenger. The brand holds 51.74% valid recommendation coverage, third in the tracked set behind Talkspace at 75.8% and BetterHelp at 64.2%, and it recorded the largest baseline-to-current increase in the category, up 12.3 points since July 2026. It is also the only tracked brand whose coverage rose in each of the three months measured, moving from 39.4% in July 2026 to 43.5% in August 2026, 48.8% in September 2026, and 51.7% in October 2026.

The movement is not confined to presence. Raw mention presence rose from 49.6% in July 2026 to 62.75% in October 2026, a 13.15-point increase. Top-three recommendation rate rose from 26.1% to 41.47%, and rank-one recommendation rate rose from 10.0% to 16.33%. Valid recommendation count rose from 201 to 282 over the same span. Grow Therapy is converting added visibility into recommendation credit, not just appearing more often.

Framing quality is strong. Grow Therapy recorded a net sentiment score of 0.8275 in October 2026, with 283 positive mentions, 59 neutral mentions, and zero negative mentions across 342 present observations. That places it above Talkspace at 0.7809 and BetterHelp at 0.7427, and behind only Brightside Health at 0.9259 among the tracked set.

The strongest platform signal is AI Overviews, where Grow Therapy holds 52.99% valid recommendation coverage and a 19.40% rank-one rate. This platform carries the largest mention volume of any surface in the dataset at 89 mentions. Perplexity is the second-strongest surface at 43.10% coverage, and AI Mode shows the highest rank-one rate of any platform at 25.69%. The clearest platform gap is ChatGPT, where the brand holds 47.06% coverage but only a 1.96% rank-one rate, meaning it is shortlisted frequently and placed first almost never on that surface.

The weakest cluster position is structural rather than brand-specific. All 545 qualified observations in October 2026 fell into the Brand Recommendation cluster. The Pricing and Value and Multi-Brand Comparison clusters recorded zero qualifying observations in both July 2026 and October 2026, so the public benchmark cannot yet describe how AI frames Grow Therapy's cost or head-to-head positioning. Two high-severity factual inconsistencies were detected for Grow Therapy across ChatGPT, Copilot, and AI Mode, one on psychiatry and medication management availability and one on insured session cost.

What Grow Therapy Is Winning

Questions This Section Answers

• How does Grow Therapy's coverage growth compare to Talkspace and BetterHelp?
• What distinguishes Grow Therapy's rank-one performance from brands like Brightside Health?
• Where does Grow Therapy achieve the strongest recommendation coverage across platforms?

Grow Therapy holds the largest baseline-to-current coverage gain in the category. Valid recommendation coverage rose 12.3 points from July 2026 to October 2026, ahead of Talkspace at 9.1 points and BetterHelp at 8.5 points. It is the only brand in the tracked set with a three-month upward streak.

The brand's rank-one rate more than held pace with its coverage growth. Rank-one recommendation rate rose from 10.0% in July 2026 to 16.33% in October 2026, an increase of more than half its July level. That distinguishes Grow Therapy from brands such as Brightside Health, which holds 15.41% top-three coverage but only a 0.37% rank-one rate.

Framing quality is a genuine strength. Grow Therapy recorded zero negative mentions across 342 present observations in October 2026, and its 0.8275 net sentiment score sits above both category leaders. The brand is described positively or neutrally in every qualified observation where it appears.

Platform breadth is also a win. Grow Therapy holds recommendation coverage above 40% on five of the six tracked surfaces: AI Overviews at 52.99%, Copilot at 65.82%, Gemini at 50.63%, AI Mode at 48.61%, and Perplexity at 43.10%. Only ChatGPT sits below that threshold at 47.06%, and even there the brand is present in nearly half of qualified observations.

Where Grow Therapy Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Grow Therapy's rank-one rate lag behind its top-three rate?
• Where is Grow Therapy most often shortlisted but not placed first?
• How do the service-scope and pricing conflicts affect how AI platforms describe Grow Therapy?

The clearest gap is first-position placement. Grow Therapy holds a 41.47% top-three rate against a 16.33% rank-one rate in October 2026. That means roughly three of every five responses that place the brand in the top three place it second or third rather than first. Talkspace converts a comparable pattern far more efficiently, holding a 71.19% top-three rate and a 27.34% rank-one rate, and BetterHelp holds a 58.72% top-three rate and a 24.04% rank-one rate.

The gap is widest on ChatGPT. Grow Therapy holds 47.06% valid recommendation coverage on that surface but only a 1.96% rank-one rate, meaning it is shortlisted in nearly half of qualified ChatGPT observations and placed first in fewer than one in fifty. On the same surface, Talkspace holds a 54.90% rank-one rate and BetterHelp holds a 7.84% rank-one rate. ChatGPT is the single largest platform opportunity in the dataset by rank-one displacement.

The brand is also displaced at the cluster level. Grow Therapy holds the highest captured share of AI opportunity in the category at 13.82%, ahead of Talkspace at 13.00% and BetterHelp at 10.30%, but Talkspace still leads the Best Online Therapy Services cluster on recommendation value. Grow Therapy's 68,718.62 in monthly AI recommendation value sits below Talkspace's 78,228.97, even though Grow Therapy's total AI Visibility Authority Value of 111,076.20 exceeds Talkspace's 104,493.13. The difference is composition: Grow Therapy's advantage comes disproportionately from visibility assist value rather than from recommendation-stage credit.

Two high-severity factual inconsistencies are actively shaping how AI platforms describe the brand. On the question "What is the best mental health virtual care?", AI Mode stated that Grow Therapy connects users with in-network licensed therapists and psychiatrists, citing a third-party review page and a Forbes health article, while Copilot stated that Grow Therapy is therapy only and does not offer psychiatry or medication management, citing HelpGuide, TeleRanked, and ChoosingTherapy. Those claims cannot both be true.

On the question "What is the best platform for online-therapy?", ChatGPT stated an average insured session cost of about $21, citing Grow Therapy's own how-it-works page and a BetterHelp cost article, while Copilot listed $75 or more per session, citing the same third-party review cluster. The flagged source on the ChatGPT side is Grow Therapy's own how-it-works page, which states that most clients start in two days and pay on average $21 per session or less with insurance. That page is being retrieved and cited correctly, but a competing source set is producing a materially different price claim on another platform.

Biggest Opportunity

Questions This Section Answers

• Where can Grow Therapy most effectively convert shortlist presence into first-choice placement?
• What would closing the ChatGPT rank-one gap mean for Grow Therapy's competitive position?

The single biggest opportunity is converting Grow Therapy's rising shortlist presence into first-choice placement inside the Brand Recommendation cluster, starting with ChatGPT. The brand already holds 47.06% recommendation coverage on ChatGPT and 65.82% on Copilot, so the discovery layer is working. What is missing is the rank-one conversion that separates a shortlisted option from the answer a buyer acts on. Closing the ChatGPT rank-one gap from 1.96% toward the 16.33% the brand already achieves across all surfaces would move Grow Therapy from a strong third-place challenger into direct contention with BetterHelp for the second position, and would do so on the surface where the brand's own how-it-works page is already being retrieved and cited.

Competitive Landscape

Questions This Section Answers

• How does Grow Therapy's recommendation performance compare to Talkspace and BetterHelp?
• What does the three-tier structure of the category suggest about Grow Therapy's position?

Talkspace holds the strongest recommendation-stage position in the Online Therapy category, followed by BetterHelp, with Grow Therapy as the clear third and the fastest-rising brand in the tracked set. The table below shows where each tracked brand sits on recommendation-stage metrics in October 2026.

Average recommended rank covers rank-eligible recommendations only.

Grow Therapy sits third on both top-three rate and rank-one rate, and third on average recommended rank at 2.3345, behind Talkspace at 1.908 and BetterHelp at 1.9559. Its sentiment score of 0.8275 is the highest among the top three brands and third-highest in the tracked set. The table shows a clear three-tier structure: Talkspace and BetterHelp at the top, Grow Therapy alone in the middle tier with a 26-point top-three lead over the fourth-ranked brand, and a compressed field below.

AI Response Inconsistency Alerts

Questions This Section Answers

• Which AI platforms made conflicting claims about Grow Therapy's psychiatry and medication management availability?
• Where do ChatGPT and Copilot disagree on Grow Therapy's insured session cost?
• What sources are driving the conflicting price claims across platforms?

Two critical or high-severity factual inconsistencies were detected for Grow Therapy across three AI platforms: ChatGPT, Copilot, and AI Mode.

The first conflict concerns psychiatry and medication management availability, rated high severity with 0.9 confidence. When asked "What is the best mental health virtual care?", AI Mode stated that Grow Therapy connects users with in-network licensed therapists and psychiatrists, citing a third-party review page titled "The 10 Best Online Therapy Companies (2026)" and a Forbes health article titled "10 Best Online Therapy Platforms In 2026: Tested & Reviewed." Copilot, answering the same question, stated that Grow Therapy offers therapy only and does not provide psychiatry or medication management, citing HelpGuide, TeleRanked, and ChoosingTherapy. These two claims cannot both be true, and the conflict sits directly on a service-scope question that affects which buyers consider the brand.

The second conflict concerns session cost with insurance, rated high severity with 0.9 confidence. When asked "What is the best platform for online-therapy?", ChatGPT stated an average insured session cost of about $21, citing Rula, Grow Therapy's own how-it-works page, and a BetterHelp cost article. Copilot, answering the same question, listed $75 or more per session, citing the same HelpGuide, TeleRanked, and ChoosingTherapy source cluster. The flagged source on the ChatGPT side is Grow Therapy's own how-it-works page, which states that most clients start in two days and pay on average $21 per session or less with insurance, with 0.98 confidence. A second flagged source on the same side is a BetterHelp cost article noting that co-pays average about $23 per session for eligible members, with 0.9 confidence. The two price claims are incompatible for the same platform, and the discrepancy appears to originate in which source set each platform retrieves rather than in Grow Therapy's own published pricing language.

Prompt Evidence

ChatGPT / Best Online Therapy Services Prompt: "What is the best platform for online-therapy?" Result: Grow Therapy was recommended in 47.06% of qualified ChatGPT observations but placed first in only 1.96%, and ChatGPT cited Grow Therapy's own how-it-works page while stating an average insured session cost of about $21.

Copilot / Best Online Therapy Services Prompt: "What is the best mental health virtual care?" Result: Grow Therapy appeared in 65.82% of qualified Copilot observations, the brand's strongest platform by coverage, but Copilot stated the brand is therapy only and listed session costs at $75 or more, contradicting both AI Mode and ChatGPT.

AI Mode / Best Online Therapy Services Prompt: "What is the best mental health virtual care?" Result: Grow Therapy was recommended in 48.61% of qualified AI Mode observations with a 25.69% rank-one rate, the brand's strongest first-position performance on any surface, and AI Mode stated the brand connects users with both therapists and psychiatrists.

Perplexity / Best Online Therapy Services Prompt: "What is the best online therapy option?" Result: Grow Therapy was recommended in 43.10% of qualified Perplexity observations with an 8.62% rank-one rate, a surface where the brand is shortlisted regularly but rarely placed first.

What CiteWorks Studio Would Do Next

Questions This Section Answers

• Which prompt-level actions should Grow Therapy prioritize to improve first-position placement?
• How should Grow Therapy address the service-scope and pricing inconsistencies across AI platforms?
• What citation and authority gaps does Grow Therapy need to close relative to category leaders?

Phase 1: AI Visibility Market Discovery Audit. Map every qualified prompt where Grow Therapy is shortlisted but not placed first, with priority on ChatGPT, and identify which competitor takes rank one in each displaced response.

Phase 2: Recommendation Readiness Plan. Prioritize the service-scope and pricing inconsistencies, since both conflicts sit on questions buyers ask before they shortlist, and align the brand's own pages with the claims AI platforms are already retrieving.

Phase 3: Owned Answer Layer Buildout. Strengthen Grow Therapy's own pages on psychiatry and medication management availability and on insured session cost so the correct claim is the easiest one for AI systems to retrieve and cite.

Phase 4: Citation and Authority Layer Development. Grow Therapy's domain appeared at rank ten among cited domains in October 2026 with 131 citations, behind betterhelp.com at 412 and talkspace.com at 329, so the source footprint has room to expand relative to the category leaders.

Phase 5: Monthly AI Visibility and Recommendation Tracking. Track rank-one rate by platform month over month, since coverage is already rising and first-position placement is the metric that now separates Grow Therapy from BetterHelp.

Why This Matters

Questions This Section Answers

• What is the difference between being shortlisted and being named first in AI recommendations?
• Why is fixing the owned answer layer critical for Grow Therapy's first-choice placement?

Grow Therapy is winning the discovery stage and losing part of the decision stage. The brand is present in 62.75% of qualified observations and recommended in 51.74% of them, but it is placed first in only 16.33%. In a category where AI systems are producing recommendation-shaped answers in 58.5% of qualified observations, up 10.5 points since July 2026, the difference between being shortlisted and being named first is the difference between being considered and being chosen.

The next move is not more visibility. It is targeted correction of the prompt, page, and citation layers that determine placement. Two high-severity factual conflicts are already shaping how ChatGPT, Copilot, and AI Mode describe Grow Therapy's service scope and pricing, and both sit on questions buyers ask before they commit. Fixing the owned answer layer and expanding the citation footprint is what turns a rising shortlist position into a first-choice recommendation.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Grow Therapy in October 2026, that is (283 × 1 + 59 × 0 + 0 × -1) / 342, which produces a score of 0.8275.

This matters because unclassified mention counts are misleading. A brand that appears in 342 responses but is described cautiously in half of them is not in the same position as a brand that appears in 342 responses and is framed positively in nearly all of them. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it separates the question of whether a brand is being discussed from the question of how it is being described when it is.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Grow Therapy's AI recommendation position in the Online Therapy category for October 2026. It is not a client implementation case study and does not describe work performed by CiteWorks Studio on Grow Therapy's behalf.
2. The reporting window is October 2026, with baseline comparison to July 2026 and intermediate readings from August 2026 and September 2026.
3. Six AI and search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. All six recorded at least one qualified observation in the reporting month.
4. The October 2026 run began with 800 prompt-surface observations and 471 unique questions. Of those, 800 mentioned a tracked brand or competitor, 762 were relevant, 38 were irrelevant, and 545 qualified for the public benchmark denominator.
5. The competitor universe contains ten tracked brands: Talkspace, BetterHelp, Grow Therapy, Brightside Health, Online-Therapy.com, Amwell, Regain, 7 Cups, Calmerry, and Cerebral.
6. One public high-intent cluster carried sufficient coverage in October 2026: Best Online Therapy Services, classified at the consideration buyer stage. The Online Therapy Platform Comparisons and Online Therapy Pricing and Cost clusters recorded zero qualified observations in both July 2026 and October 2026.
7. Stage 0 extraction produced the prompt-level observations that retain the query, the AI or search surface, the full answer, the brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources.
8. A mention is counted when a tracked brand appears anywhere in an AI or search response for a qualified observation. A valid recommendation is counted only when the dataset explicitly marks the brand as recommended or shortlisted. Negative, neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations.
9. Top-three rate is the share of qualified observations where the brand is placed in the top three recommended slots. Rank-one rate is the share of qualified observations where the brand is the first recommendation. Average recommended rank covers rank-eligible recommendations only.
10. Net sentiment describes benchmark framing, not customer sentiment. It is calculated as positive mentions minus negative mentions across all mentions, on a scale from -1 to 1.
11. Two high-severity factual inconsistencies were detected for Grow Therapy across ChatGPT, Copilot, and AI Mode. Both are reported in the AI Response Inconsistency Alerts section above.
12. Limitations: the qualified denominator of 545 observations is smaller than the raw collection of 800 prompts, and percentages reflect the qualified set only. Movement between months is directional analysis, not proof of cause. The public benchmark does not measure market share, revenue, attributable sales, organic-search ranking positions, social media mention volume, private or sponsored channels, or causality from a metric movement alone. The Pricing and Value and Multi-Brand Comparison clusters remain unmeasured, so this report cannot describe how AI frames Grow Therapy's cost or head-to-head positioning.

See How AI Is Recommending Your Brand

The public benchmark shows where Grow Therapy stands in the category. A company-level AI visibility audit maps the specific prompts, surfaces, competitors, and evidence sources behind each recommendation, including the two service-scope and pricing conflicts currently appearing across ChatGPT, Copilot, and AI Mode. That prompt-level view is what turns a rising coverage rate into a prioritized plan for first-position placement.